0.6900USD+2.99%Mkt Cap: 8.07M USDP/E: —Last update: 2026-06-01
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap8.07M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.00M USD
Revenue/Share—
Last Price0.6900 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS87166L1008
Valuation
P/E (Trailing)—
P/E (Forward)-1.43
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.66
EPS (TTM)-0.06
EPS (Forward)-0.47
52W Range
0.540011% of range1.960
52W High1.960 USD
52W Low0.5400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.47%
ROA-6.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.36M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh1.014 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 28, 2017
Splits
Last Split1:7
Split DateAug 28, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.70M
Float—
Insiders22.60%
Institutions35.28%
Short Interest
Short Ratio0.1d
Short % Float0.20%
Short % Out.0.09%
Shares Short10.41K
Short (prev mo.)15.43K
Technical
SMA 500.6423 (+7.4%)
SMA 2001.093 (-36.9%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)8.11K
Avg Vol (10d)18.99K
Technical Indicators
RSI (14)58.3
MACD0.0035
MACD Signal0.0035
MACD Hist.+0.0001
BB Upper0.6868 USD
BB Middle0.6367 USD
BB Lower0.5865 USD
BB Width15.75%
ATR (14)0.0363 USD
Vol Ratio (20d)0.01x